1 abr 2021
Clever Leaves Expands its Presence in Brazil and Peru Through Verdemed Partnership
Clever Leaves Partners with Leading Latin American Company to Provide EU-GMP and INVIMA Certified Products to Brazil and Peru
NEW YORK, April 01, 2021 (GLOBE NEWSWIRE)
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced an agreement with Verdemed Holdings Inc. (“Verdemed”), a Latin American pharmaceutical cannabis company based in Toronto, Canada, to supply finished CBD products for the Brazilian and Peruvian markets. The initial portfolio of products includes finished formulations of CBD oral solutions with different concentrations used for different indications.
Clever Leaves Reports Fourth Quarter and Full Year 2020 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership
NEW YORK, March 17, 2021 (GLOBE NEWSWIRE)
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ( Clever Leaves or the Company ), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the signing of a supply agreement with Ethypharm ( Ethypharm ), a European manufacturer and distributor of pharmaceutical products, for the sale of medical cannabis extracts produced in Clever Leaves EU-GMP certified facilities in Colombia. The initial portfolio of products includes high-CBD, high-THC, and balanced CBD and THC formulations developed exclusively by Clever Leaves to meet the regulatory needs of the German market.
Pharmaceutical Company Ethypharm Partners With Clever Leaves To Sell Cannabis In Germany benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, March 02, 2021 (GLOBE NEWSWIRE)
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that the Colombian Technical Quotas Group (“TQG”) authorized Clever Leaves’ Colombian operations to manufacture up to approximately 59,000 kilograms of cannabis into dried flower derivatives. According to the International Narcotics Control Board’s publicly disclosed data, Clever Leaves’ total allocation represents 50% of Colombia’s total quota and approximately 18% of the world’s legal medical cannabis production quota for 2021.
The new 2021 production quota authorizes Clever Leaves to extract medical cannabis and the total quantity allocated to their company is forecasted to be sufficient towards meeting the aggregate international demand for Clever Leaves’ products. To date, Clever Leaves has successfully exported to m